Voquz Labs AG (VQLA.VI) specializes in software solutions for SAP license management, authorization management, compliance management, and IT spend optimization; its core products include samQ for SAP license optimization and cost reduction, setQ for automated SAP authorization management, visoryQ for SAP ERP business case modeling and S/4HANA migration support, and remQ for internal control system automation and fraud prevention; the company also provides SAP license advisory services. Founded in 2015 and headquartered in Berlin, Germany, Voquz Labs operates globally with offices in New York and Mexico City in the Americas, Amsterdam and Cluj-Napoca in Europe, and Singapore, Kuala Lumpur, London, and Cape Town in Asia-Pacific, serving over 230 private enterprise customers primarily in these regions. In March 2025, Main Capital Partners acquired a 95.3% stake in the company for a lower double-digit million euro valuation, with the transaction closing by April 2025 and plans for a squeeze-out of minority shareholders; this follows the 2023 acquisition of Remedyne, whose products were integrated and rebranded as remQ, and supports ongoing M&A strategy in the SAP add-on space including potential cross-selling opportunities; recent partnerships such as with PwC and the launch of visoryQ further drive growth amid S/4HANA transformations.